ARCHIVES

Perjeta, Herceptin & Docetaxel Combination Extended Survival in HER2-Positive Disease

This article is from The Cancer Letter archive.

Vol. 35 No. 12 | December 28, 2012

Download PDF Visit The Full Archive

Related Articles

ACS Announces New Awards for Nurses

October 30, 1987

NCI Denies GAO Report That Backlog Still Exists, Says Most were Published As Research Results

May 18, 1979

Broder Says No Thanks To Acknowledgement For Paper’s Title

June 6, 1997

NIH Awards 24 More Grants For Women’s Health Initiative

October 14, 1994

Sieving Named Director, National Eye Insitute.

January 19, 2001

NCAB May Make Its Recommendation On Comprehensive Center Issues At September Meeting

August 5, 1988